2m 2m 2m 2m 2m 2m 2m
CG ONCOLOGY (CGON)
NASDAQ
$62.50-$0.05 (-0.07%)
Price as of Oct 22, 2026 7:30 PM EDT- $5.5BMarket Cap
- 48.98%1-Year Change
- BiotechnologyIndustry
CG ONCOLOGY (CGON)
$62.50-$0.05 (-0.07%)
CGON | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $62.54 | ||
Change | +$0.30 (+0.48%) | ||
Open | $61.95 | ||
High | $63.19 | ||
Low | $61.40 | ||
Previous Close | $62.24 | ||
Volume | 579,519 | ||
30-Day Average Volume | 1,028,776 | ||
1-Week Change | 1.10% | ||
1-Month Change | -19.55% | ||
1-Year Change | 48.98% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 88.6M | ||
Total Assets | $1.1B | ||
Market Cap | $5.5B | ||
Enterprise Value | $5.5B | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$79.1M | ||
Free Cash Flow | -$46.9M | ||
EBIT | -$79.1M | ||
EBITDA | -$78.2M | ||
Net Working Capital | $1.0B | ||
EPS | -$0.90 | ||
Enterprise Value/EBITDA | -70 | ||
Enterprise Value/Revenue | 4,795 | ||
P/B | 5 | ||
P/E | -69 | ||
PEG | 3 | ||
Price/Free Cash Flow | -118 | ||
Price/Operating Cash Flow | -119 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue